Literature DB >> 15831578

Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard.

Sining Chen1, Patrice Watson, Giovanni Parmigiani.   

Abstract

Microsatellite instability (MSI) testing is a common screening procedure used to identify families that may harbor mutations of a mismatch repair (MMR) gene and therefore may be at high risk for hereditary colorectal cancer. A reliable estimate of sensitivity and specificity of MSI for detecting germline mutations of MMR genes is critical in genetic counseling and colorectal cancer prevention. Several studies published results of both MSI and mutation analysis on the same subjects. In this article we perform a meta-analysis of these studies and obtain estimates that can be directly used in counseling and screening. In particular, we estimate the sensitivity of MSI for detecting mutations of MSH2 and MLH1 to be 0.81 (0.73-0.89). Statistically, challenges arise from the following: (a) traditional mutation analysis methods used in these studies cannot be considered a gold standard for the identification of mutations; (b) studies are heterogeneous in both the design and the populations considered; and (c) studies may include different patterns of missing data resulting from partial testing of the populations sampled. We address these challenges in the context of a Bayesian meta-analytic implementation of the Hui-Walter design, tailored to account for various forms of incomplete data. Posterior inference is handled via a Gibbs sampler.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831578      PMCID: PMC2274000          DOI: 10.1093/biostatistics/kxi021

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  46 in total

1.  Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements.

Authors:  S Gad; A Aurias; N Puget; A Mairal; C Schurra; M Montagna; S Pages; V Caux; S Mazoyer; A Bensimon; D Stoppa-Lyonnet
Journal:  Genes Chromosomes Cancer       Date:  2001-05       Impact factor: 5.006

2.  Screening without a "gold standard": the Hui-Walter paradigm revisited.

Authors:  W O Johnson; J L Gastwirth; L M Pearson
Journal:  Am J Epidemiol       Date:  2001-05-01       Impact factor: 4.897

3.  Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer.

Authors:  A Loukola; R Salovaara; P Kristo; A L Moisio; H Kääriäinen; H Ahtola; M Eskelinen; N Härkönen; R Julkunen; E Kangas; S Ojala; J Tulikoura; E Valkamo; H Järvinen; J P Mecklin; A de la Chapelle; L A Aaltonen
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness.

Authors:  Carolina M Reyes; Brian A Allen; Jonathan P Terdiman; Leslie S Wilson
Journal:  Cancer       Date:  2002-11-01       Impact factor: 6.860

5.  Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition.

Authors:  D Calistri; S Presciuttini; G Buonsanti; P Radice; I Gazzoli; V Pensotti; P Sala; M Eboli; S Andreola; A Russo; M Pierotti; L Bertario; G N Ranzani
Journal:  Int J Cancer       Date:  2000-01-20       Impact factor: 7.396

6.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

7.  Microsatellite instability-a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer.

Authors:  C Lamberti; R Kruse; C Ruelfs; R Caspari; Y Wang; M Jungck; M Mathiak; H R Malayeri; W Friedl; T Sauerbruch; P Propping
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

8.  Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.

Authors:  Elise Renkonen; Yange Zhang; Hannes Lohi; Reijo Salovaara; Wael M Abdel-Rahman; Mef Nilbert; Kristiina Aittomaki; Heikki J Jarvinen; Jukka-Pekka Mecklin; Annika Lindblom; Paivi Peltomaki
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

9.  Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours.

Authors:  Andrew Ruszkiewicz; Graeme Bennett; James Moore; Jim Manavis; Barney Rudzki; Linda Shen; Graeme Suthers
Journal:  Pathology       Date:  2002-12       Impact factor: 5.306

10.  Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.

Authors:  K M Lin; M Shashidharan; A G Thorson; C A Ternent; G J Blatchford; M A Christensen; P Watson; S J Lemon; B Franklin; B Karr; J Lynch; H T Lynch
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.267

View more
  7 in total

1.  BayesMendel: an R environment for Mendelian risk prediction.

Authors:  Sining Chen; Wenyi Wang; Karl W Broman; Hormuzd A Katki; Giovanni Parmigiani
Journal:  Stat Appl Genet Mol Biol       Date:  2004-09-17

2.  Random Effects Models in a Meta-Analysis of the Accuracy of Two Diagnostic Tests Without a Gold Standard.

Authors:  Haitao Chu; Sining Chen; Thomas A Louis
Journal:  J Am Stat Assoc       Date:  2009-06-01       Impact factor: 5.033

3.  Prediction of germline mutations and cancer risk in the Lynch syndrome.

Authors:  Sining Chen; Wenyi Wang; Shing Lee; Khedoudja Nafa; Johanna Lee; Kathy Romans; Patrice Watson; Stephen B Gruber; David Euhus; Kenneth W Kinzler; Jeremy Jass; Steven Gallinger; Noralane M Lindor; Graham Casey; Nathan Ellis; Francis M Giardiello; Kenneth Offit; Giovanni Parmigiani
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

4.  Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO.

Authors:  Hormuzd A Katki; Amanda Blackford; Sining Chen; Giovanni Parmigiani
Journal:  Stat Med       Date:  2008-09-30       Impact factor: 2.373

Review 5.  Estimation of diagnostic test accuracy without full verification: a review of latent class methods.

Authors:  John Collins; Minh Huynh
Journal:  Stat Med       Date:  2014-06-09       Impact factor: 2.373

6.  Incorporating medical interventions into carrier probability estimation for genetic counseling.

Authors:  Hormuzd A Katki
Journal:  BMC Med Genet       Date:  2007-03-22       Impact factor: 2.103

7.  Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry.

Authors:  Jiyoon Jung; Youngjin Kang; Yoo Jin Lee; Eojin Kim; Bokyung Ahn; Eunjung Lee; Joo Young Kim; Jeong Hyeon Lee; Youngseok Lee; Chul Hwan Kim; Yang-Seok Chae
Journal:  J Pathol Transl Med       Date:  2017-02-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.